Neuroprotective Drugs Market

Neuroprotective Drugs Market - Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029

Neuroprotective Drugs Market Segmented By drug class such as Anesthetics, Antagonists, Antidepressants, Antiepileptic drugs, Anti-inflammatory drugs, Antioxidants/free radical scavengers, Cytokines, Ion Channel Blockers, Immunomodulators and others

Market Overview

Neuroprotective drugs are the drugs used for the management of the neuronal structure and function. Neuroprotective drugs can cut the number of deaths which accounts for 6 million deaths due to stroke. According to the Global Burden of Disease report from the World Health Organization about 50 million people have epilepsy worldwide.

Neuroprotective drugs can cut the economic burden of diseases on GDP spent on healthcare. Neuroprotective drugs are useful in treating a range of indications including ischemic strokes, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, brain injuries, and other neurodegenerative disorders.

Life expectancy has risen over the last few decades in both emerging and developed countries and the geriatric population with neurological disorders or degenerative problems have also increased. This gives a large scope for neuroprotective drug manufacturers to capitalize on the opportunity by entering the niche markets or expanding the reach of already available drugs.

Increasing incidence and prevalence of various neurological diseases such as dementia, autism, Alzheimer’s disease and other rare diseases expected to drive the growth of the neuroprotective drugs market. Growing incidence of surgeries is anticipated to drive the growth of the neuroprotective drugs market.

The rising number of people suffering from degenerative disorders expected to fuel the growth of neuroprotective drugs market. The incurable diseases like multiple sclerosis and amyotrophic lateral sclerosis are expected to rise the demand steadily over the years for neuroprotective drugs.

Level of awareness regarding the detection of glaucoma and diabetic retinopathy is anticipated to be one of the factors leading the growth of neuroprotective drugs. An ever-increasing number of traumatic injuries due to recreational activities and transportation is expected to be one of the main drivers of neuroprotective drugs.

Find Out More about the Report Coverage

Market Segmentation

By drug class
  • Anesthetics
  • Antagonists
  • Antidepressants
  • Antiepileptic drugs
  • Anti-inflammatory drugs
  • Antioxidants/free radical scavengers
  • Cytokines
  • Ion Channel Blockers
  • Immunomodulators
  • Others
By application
  • Dementia
  • Epilepsy
  • Multiple sclerosis
  • Parkinson’s disease
  • Stroke
  • Traumatic brain injuries
  • Others
By route of administration
  • Oral
  • Topical
  • Epidural
  • Intravenous
By distribution channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Regional Outlook

The key players are focusing more on clinical trials related to neuroprotective drugs through collaboration with research institutes generating more fund from government sources. The global neuroprotective drugs market is expected to experience steady growth over the forecast period due to increasing prevalence of neurological disorders.

By drug class, immunomodulators are expected to be the most lucrative segment in the global neuroprotective drugs market. On the basis of application type, stroke is expected to be the most revenue-generating segment in global neuroprotective drugs market.

Based on route of administration, the oral route is expected to be the most lucrative segment in the global neuroprotective drugs market. By distribution channel, retail pharmacies is expected to be the most lucrative segment in the global neuroprotective drugs market owing to higher patient footfall.

The global neuroprotective drugs market is expected to be dominated by North America due to higher prevalence of the pain. Europe is expected to be the second most lucrative region in the global neuroprotective drugs market owing to higher adoption of the neuroprotective drugs.

Asia-Pacific is expected to be the fastest-growing neuroprotective drugs market due to large population residing in countries such as India and China. Latin America market is expected to experience steady growth whereas MEA expected to be the least lucrative market due to lower adoption.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Key Participants

The key participants operating in the global neuroprotective drugs market are: Teva Pharmaceutical Industries Ltd, Biogen, Novartis AG, Janssen Global Services, LLC, Sunovion Pharmaceuticals Inc., Pfizer Inc., Sanofi, Allergan, AstraZeneca, Acorda Therapeutics and others.

Explore Persistence Market Research’s expertise in promulgation of the business !

The report covers exhaustive analysis on:

  • Neuroprotective drugs Market Segments
  • Neuroprotective drugs Market Dynamics
  • Historical Actual Market Size, 2013 - 2017
  • Neuroprotective drugs Market Size & Forecast 2018 to 2024
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance


Effervescent Products Market

The Global Effervescent Products market is expected to have a CAGR of 6.50% from USD 41,217.9 Million in 2022 to USD 64,088.9 Million in 2029..

Injectable Drug Delivery Market

Global Drug Delivery Devices market had reached to be USD 22 Bn in 2021 and is expected to attain US$ 29 Bn by 2026, growing at a CAGR of 6% during the forecast period of 2021-26.

Rheumatoid Arthritis Treatment Market

Rheumatoid Arthritis Treatment Market is expected to reach a market value of over US$ 30,000 Mn by the end of 2025, growing at a CAGR of 6.2% during the forecast period..

Cancer Supportive Care Products Market

Global Cancer Supportive Care Products Market across the world will translate into a revenue of US$ 31,700.0 Mn along with a healthy CAGR by the end of 2021.

Our Clients

Our Clients